Phase I Trial of Sorafenib in Combination With Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent.
Phase of Trial: Phase I
Latest Information Update: 01 Oct 2014
At a glance
- Drugs Sorafenib (Primary)
- Indications Bladder cancer
- Focus Adverse reactions
- 19 Jul 2011 Planned End Date changed from 1 Dec 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 19 Jul 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 30 Jul 2010 Planned end date changed from 1 Sep 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.